SCHEMBL26103441

SCHEMBL26103441

CCOC(=O)c1sc(C)nc1OCC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.47
ALDH1A1 P00352 5/20 0.44
HPGD P15428 2/20 0.44
CYP1A2 P05177 1/20 0.44
HSD17B10 Q99714 4/20 0.44
GAA P10253 2/20 0.44
TSHR P16473 1/20 0.44
HTT P42858 1/20 0.44
CDC7 O00311 4/20 0.42
DBF4 Q9UBU7 4/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 2/20 0.41
ROCK2 O75116 1/20 0.39
TRPM8 Q7Z2W7 2/20 0.39
MAPT P10636 1/20 0.39
RAB9A P51151 1/20 0.39
MC4R P32245 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20214829 0.88 NPC1 (0.47) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL20654264 0.87 NPC1 (0.51) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL20213983 0.82 ALDH1A1 (0.43) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL5651486 0.81 CDC7 (0.59) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL8236741 0.81 ALDH1A1 (0.46) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL31078569 0.78 ALDH1A1 (0.44) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL9199237 0.78 NPC1 (0.49) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL20214190 0.78 NPC1 (0.42) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL5112527 0.77 NPC1 (0.48) NPC1ALDH1A1HPGDCYP1A2HSD17B10
SCHEMBL31078794 0.76 ALDH1A1 (0.44) NPC1ALDH1A1HPGDCYP1A2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260132127-A1 NOVEL SPIRO COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2026-05-14 US disclosed
CN-118176179-A Novel spiro compounds 田边三菱制药株式会社 2024-06-11 CN disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 WO disclosed
WO-2023074847-A1 NOVEL SPIRO COMPOUND 田辺三菱製薬株式会社 2023-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260132127-A1 NOVEL SPIRO COMPOUND TRHR, NR3C2, THRB NPC1 457/4885ALDH1A1 1063/4885HPGD 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.